Biotechnology deals with mainly four clas-ses of biomolecules, namely - nucleic acids, proteins, carbohydrates and lipids. A biotechnologist essentially adds, subtracts, multiplies or divides these biomolecules for benefit to society. The conventional pharmacy education has been looking at synthetic molecules in order to treat the symptoms of the disease. With the discovery of antibiotics in the 1940s onward we have been trying to destroy the microorganism, which has been the causative agent. Prior to 1940s, the attempt to treat diseases has been through exploiting the innate immune system or through passive immunization. This mode of treatment largely became unfashionable after 1940s. With the development of recombinant DNA technology, hybridoma technology and stem cell technology, it is now possible to do identify and treat the diseases at the molecular level. This calls for a paradigm shift in pharmacy education where we need to reduce some of the currently existing teaching programmes, which have become outmoded and include the study of new drugs, which are being discovered through modern biotechnology. This is especially very important in the light of the WTO-TRIP^S agreement, which becomes operational from 2005 onwards. This calls for a new brand of pharmacist who can become a major player in the global market.